Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Implementing an Automated DOE in Twin Screw Wet Granulation
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Newsmakers Q&A: BioVectra
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Parexel Announces CEO Transition
DifGen Acquires FDA-Registered Manufacturing Facility
Quotient Sciences Makes Executive Leadership Team Appointments
Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
DifGen Acquires FDA-Registered Manufacturing Facility
Samsung Life Science Fund Invests in BrickBio
Assurance of Global Pharma Supply
Upgraded Syngene Biologics Facility to Be Operational in Second Half of 2024
GeminiBio Introduces Aseptic Assurance System
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
Assurance of Global Pharma Supply
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Parexel Announces CEO Transition
Samsung Life Science Fund Invests in BrickBio
Selvita Adds Antibody Discovery and Development Capabilities
The High Five: Key Regulatory Topics for Drug Development in 2024
Pace Life Sciences Acquires New Jersey Lab
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
The High Five: Key Regulatory Topics for Drug Development in 2024
The “Hows” of Drug Shortages
SGS Lab in Fairfield, NJ Earns ISO/IEC 17025:2017 Certification
The Road Ahead for CDMOs in 2024
Never Assume!
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
TaiMed Biologics
Lannett CDMO
BioTechnique
CMC Pharmaceuticals
Vetter Pharma International
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
TaiMed Biologics
Lannett CDMO
BioTechnique
CMC Pharmaceuticals
Vetter Pharma International
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 25 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Search Results for '
antibody drug conjugate
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Advanced Degrees
Ask The Board
Ask The Experts
Back Page
Bio News & Views
Blog
Breaking News
Business Corner
Buyers Guide Companies
Case Studies
Classifieds
Columns
Company Blog
Conference Sessions
Content Microsite
Ebook
Editorial
Executive Perspective
Expert's Opinion
FDA Watch
Features
Financial Analysis
Getting Results
Glossary
I Mak
India Report
Industry Events
Infographics
Jobs
Literature / Brochures
Live From Shows
Lowe Down
Managing Your Career
News Releases
Online Exclusives
Outsourcing Survey
Pharma Beat
Podcasts
Posters
Preclinical Outsourcing
Product Releases
Salary Survey
Services
Slideshows
Sponsored Content
Top 25 Pharma & BioPharma
Top Companies Report
Trials & Filings
Videos
Webinars
White Papers / Tech Papers
Contract Service Directory Companies
View All Buyers Guide Companies »
Breaking News
|
Collaborations & Alliances
|
Drug Development
Eisai Partners with Blissbio for Antibody Drug Conjugate BB-1701
Eisai has granted BlissBio global exclusive development rights for several ADCs to use eribulin as the payload.
05.08.23
Breaking News
|
Promotions & Moves
ADC Therapeutics Appoints Jennifer Creel as CFO
Former Celgene executive brings deep oncology-focused financial expertise
Contract Pharma Staff
04.21.20
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
Navrogen, Levena Collaborate to Develop ADCs
To treat humoral immuno-suppressed cancers
02.13.20
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
HPAPI Market Trends: PCI Expands Capabilities
Michael Ellingson of PCI discusses market demand for specialty drug product capabilities and the Rockford, IL expansion
Online Exclusives
Kristin Brooks, Cotract Pharma
01.10.20
Bio News
|
Breaking News
|
Industry News
|
Information Technology
Goodwin Bio Launches Digitization Initiative
Invests in a sophisticated electronic quality solution.
11.11.19
Cytotoxics and High Potency Manufacturing
Highly Potent Expansions
CDMOs see HPAPI demand rising
S. Harachand, Contributing Editor
09.16.19
Cytotoxics and High Potency Manufacturing
API to ADC: A Journey Through High Potency
This class of compounds represents a major advance in oncology research and treatment application.
Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech
09.16.19
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
ADC Therapeutics, Freenome Enter Biomarker Development Collaboration
ADC Therapeutics to employ Freenome's multiomics platform to identify biomarkers that correlate with clinical response to ADCT-402
08.28.19
Is Your Complex Formulation Process Set Up for Success?
Often, the implementation of specialized equipment and/or processes is necessary to ensure successful formulation.
Bio News
|
Drug Development
ADC Therapeutics, SOPHiA GENETICS Partner for Biomarker Discovery
Pivotal Phase II trial to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine) in DLBCL
08.07.19
Bio News
|
Breaking News
|
Industry News
|
Promotions & Moves
|
QA/QC
|
Regulatory Affairs
Goodwin Biotechnology Bolsters Quality & Regulatory Capabilities
Names Gerald Orehostky as vice president of quality and regulatory operations
08.07.19
DAIICHI-Sankyo
...
07.15.19
Pfizer, Inc.
...
07.15.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Facilities
|
Industry News
ADC Bio’s New State of the Art Cleanroom Competed by WHP
The GMP facility has been designed to deliver next gen anticancer blockbuster ADC drugs for patients globally
07.15.19
Drug Discovery
|
Industry News
ReachBio Research Labs Offers New Services for ADCs
Includes off-target toxicity and linker stability assays for cytotoxicity evaluation
07.09.19
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Industry News
Piramal Invests $10 million in Riverview Expansion
Expands High Potency API Capability to serve the growing ADC market
06.21.19
The 20th Annual Salary Survey
Plus: packaging trends, data integrity, serialization, ADCs and expediting clinical development
Tim Wright, Editor
06.13.19
Biologics, Proteins, Vaccines
The ADC Market is Fast Evolving
Applications of ADCs are widening and improvements in the manufacturing process meet industry requirements.
Charlie Johnson, CEO, ADC Bio
06.13.19
Biologics, Proteins, Vaccines
The Biopharma Future
A look at current trends driving volume reductions in biopharmaceutical manufacturing and keys for successful outsourcing partnerships.
Karl Pinto and Dave Cunningham, Goodwin Biotechnology
05.07.19
Bio News
|
Breaking News
|
cGMP Manufacture
|
Facilities
|
Industry News
Goodwin Biotechnology Readies for Expansion
Secures significant investment in new round of growth capital financing
04.25.19
Collaborations & Alliances
|
Drug Development
ADC Therapeutics, Adagene Ink License Agreement
Will leverage Adagene’s SAFEbody technology to generate a masked antibody that will be combined with ADC Therapeutics against a solid tumor target
04.24.19
Breaking News
|
Promotions & Moves
GT Biopharma Restructures Management Team
Cataldo named chief executive officer, Weldon appointed as chief financial officer
03.26.19
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
|
R&D
LegoChem, Takeda Enter ADC Cancer Research Collaboration
Will focus on the development of antibody drug conjugates in immuno-oncology
03.25.19
CDMO Market Trends
Vivek Sharma, CEO, Piramal Pharma Solutions, discusses outsourcing trends, opportunities, and the capabilities needed for today’s (bio)pharma pipelines.
Kristin Brooks, Managing Editor, Contract Pharma
03.06.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Facilities
|
Industry News
EirGenix Opens Mfg. Plant in Taiwan
Also inks ADC deal with Oncomatryx Biopharma
01.28.19
Bio News
|
Drug Development
|
Drug Discovery
|
Industry News
|
R&D
|
Reader Showcase
Aji Bio-Pharma Introduces New ADC Mfg. Technology
AJICAP technology lets developers of ADCs to better control the location of payload conjugation to an antibody
11.28.18
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Facilities
|
Industry News
Abzena Invests $20M to Expand Integrated Biotherapeutics Offering
Includes increase in capacity to 2000 L scale in new GMP facility
11.09.18
Bio News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
Industry News
|
R&D
Daiichi Sankyo, Merck, Pfizer Enter Collaboration
To evaluate the combination of [fam-] trastuzumab deruxtecan in combination with the checkpoint inhibitor avelumab
10.25.18
HPAPI Equipment Advances
Using “glove box” facilities for safe and effective HPAPI handling and manufacturing
Salvatore Mercuri and Mattia Wiedemeier, Lonza Pharma & Biotech
10.10.18
Biologics, Proteins, Vaccines
Integrating Antibody Purification and Conjugation
An advanced manufacturing technique for transforming ADC production efficiencies
Charlie Johnson, CEO, ADC Bio
10.10.18
Bio News
|
Breaking News
|
Industry News
ADC Market Predicted to Grow to $4B
A new analysis in the CPhI Annual Report estimates the increase in growth by 2023
10.09.18
APIs
|
Breaking News
|
Cytotoxics and High Potency Manufacturing
|
Industry News
Lonza Expands HPAPI Capacity
Will add two new manufacturing suites at its Visp site for the manufacture of ADC payloads
10.08.18
Aseptic Processing
|
Bio News
|
Breaking News
|
Facilities
|
Industry News
IPS to Provide Engineering Solutions for Althea's New Mfg. Facility
Althea recently expanded operations to include manufacturing of highly potent drug products as well as ADCs
09.14.18
Bio News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Industry News
|
Process Development
Abzena Selects Sartorius as U.S. Equipment Supplier
Sartorius Stedim will equip Abzena's CDMO facilities in Bristol, PA and San Diego, CA with end-to-end process solutions
09.12.18
APIs
|
Cytotoxics and High Potency Manufacturing
HPAPI Technology Evolution
Handling of high potency compounds for API and DP from development on a laboratory scale and scale-up to commercial.
Martina Kotthaus, Jeff Dinyer, Anil Kane and Marvin Faber, Patheon, part of Thermo Fisher Scientific
09.11.18
APIs
|
Cytotoxics and High Potency Manufacturing
HPAPI Market Trends
Rising demand for targeted cancer and other treatments driving HPAPI growth.
Nigel Walker, That’s Nice/Nice Insight
09.11.18
HPAPI Outsourcing Likely to Gain Traction
A number of highly potent drugs will soon fall into the generic domain
S. Harachand, Contributing Editor
09.11.18
14 Bristol-Myers Squibb
...
07.20.18
Formulation Development
Developing Faster-to-Clinic Formulations
When standard formulation strategies fail, is there a fast path to clinic for hard-to-formulate therapeutics?
Phil Morton, Chief Technology Officer, Albumedix
06.12.18
Bio News
|
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Industry News
|
Scale-up/Technology Transfer
Telix Chooses Goodwin Bio as Mfg. Scale-up Partner
CDMO to optimize the process for cGMP manufacturing of Telix's renal cancer imaging ADC TLX-250
05.08.18
cGMP Manufacture
Changing Dynamics: The CDMO market in focus
Contract Pharma talks with executives about trends in the CDMO market
Tim Wright, Editor, Contract Pharma
04.10.18
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Industry News
ADC Bio Developing Downstream Bioconjugation Process
New manufacturing paradigm will save 25% of total costs and
02.12.18
Biologics, Proteins, Vaccines
|
cGMP Manufacture
|
Industry News
Abzena Selects Sartorius to Equip U.S. Mfg. Sites
Will provide facilities in San Diego and Bristol with process solutions in single-use format
01.04.18
APIs
Radiolabeling is Still Hot
This article is a short narrative on the labeling of APIs focused around the application of carbon-14 for small molecule, pep
Sean Kitson, Tom Moody, William Watters and David Speed, Almac
11.07.17
Collaborations & Alliances
|
Drug Development
Daiichi Sankyo, Glycotope Enter Strategic ADC Alliance
To develop ADC combining Daiichi's ADC technology with Glycotope's investigational TA-MUC1 antibody
10.30.17
Bioanalytical Services
|
Clinical Trial Materials
|
Cytotoxics and High Potency Manufacturing
|
Drug Development
|
Facilities
|
Process Development
|
Scale-up/Technology Transfer
ADC Bio Invests $11M in Bioconjugation Facility
Will provide capabilities and R&D technical services from process development through to manufacturing
09.25.17
Biologics, Proteins, Vaccines
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Industry News
Ajinomoto Althea Opens GMP Mfg. Suites
To develop and manufacture ADCs and HPAPIs
09.19.17
Drug Discovery
How Can We Predict Immunogenicity Earlier in Drug Discovery?
Identifying potential immune responses earlier in the development of biotherapeutics.
Kevin Merlo and Tim Moran, Dassault Systèmes Biovia
09.01.17
Breaking News
|
Clinical Trials
|
Collaborations & Alliances
|
Industry News
|
R&D
BMS, Daiichi Sankyo Enter Research Collaboration
Will evaluate Opdivo and DS-8201 in HER2-expressing breast and bladder cancers
08.30.17
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
Jazz, ImmunoGen in $175M Oncology Pact
Will develop and commercialize ADCs; strengthens Jazz hematology/oncology portfolio
08.30.17
Breaking News
Parexel Announces CEO Transition
DifGen Acquires FDA-Registered Manufacturing Facility
Quotient Sciences Makes Executive Leadership Team Appointments
Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
View Breaking News >
CURRENT ISSUE
March 2024
Implementing an Automated DOE in Twin Screw Wet Granulation
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Newsmakers Q&A: BioVectra
Multi-particulate Formulations – Tablets or Capsules?
Manufacturing Equipment Trends
OSD Outsourcing: Savvy CMOs Hone Skills as Complex APIs Fuel Demand
Catalent Acquisition by Novo Holdings: Evolution of the Industry(?)
The Road Ahead for CDMOs in 2024
View More >